Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Lung Cancer

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 226 articles:
HTML format



Single Articles


    July 2020
  1. SALAZAR MC, Boffa DJ
    Commentary: The majority of minorities.
    J Thorac Cardiovasc Surg. 2020;160:272-273.
    PubMed    


  2. HAMMOUD ZT
    Commentary: Despair and disparity.
    J Thorac Cardiovasc Surg. 2020;160:275.
    PubMed    


  3. CORNWELL LD, Ripley RT
    Commentary: Beyond the eyeball test.
    J Thorac Cardiovasc Surg. 2020;160:285-286.
    PubMed    


  4. JONES GD, Tan KS, Caso R, Dycoco J, et al
    Time-varying analysis of readmission and mortality during the first year after pneumonectomy.
    J Thorac Cardiovasc Surg. 2020;160:247-255.
    PubMed     Abstract available


    June 2020
  5. GILES AE, Kidane B
    Commentary: Know your enemy-Understanding futility in the battle against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2523-2524.
    PubMed    


  6. HOANG CD
    Commentary: Surgeon versus mesothelioma in a thoracic cage match.
    J Thorac Cardiovasc Surg. 2020;159:2522-2523.
    PubMed    


  7. ANDRADE R
    Commentary: Why do uniportal video-assisted thoracoscopic lobectomy?
    J Thorac Cardiovasc Surg. 2020;159:2496-2497.
    PubMed    


  8. BOFFA DJ, Salazar M
    Commentary: How surprising.
    J Thorac Cardiovasc Surg. 2020;159:2483-2484.
    PubMed    


  9. DE PERROT M
    Commentary: Is thoracic cage volume a new parameter for clinical staging in mesothelioma?
    J Thorac Cardiovasc Surg. 2020;159:2520-2521.
    PubMed    


  10. BURT BM, Lee HS, Raghuram AC, Strange C, et al
    Preoperative prediction of unresectability in malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2512-2520.
    PubMed     Abstract available


  11. HYLTON DA, Turner S, Kidane B, Spicer J, et al
    The Canada Lymph Node Score for prediction of malignancy in mediastinal lymph nodes during endobronchial ultrasound.
    J Thorac Cardiovasc Surg. 2020;159:2499-2507.
    PubMed     Abstract available


  12. VIEIRA A, Bourdages-Pageau E, Kennedy K, Ugalde PA, et al
    The learning curve on uniportal video-assisted thoracic surgery: An analysis of proficiency.
    J Thorac Cardiovasc Surg. 2020;159:2487-2495.
    PubMed     Abstract available


    May 2020
  13. PASS HI
    Commentary: Not only SMART clinically, but translationally!
    J Thorac Cardiovasc Surg. 2020;159:2094-2095.
    PubMed    


  14. BRUNELLI A
    Commentary: The power of indeterminacy.
    J Thorac Cardiovasc Surg. 2020;159:2041.
    PubMed    


  15. SESTI J, Paul S
    Commentary: Known unknowns and unknown unknowns: The case of the indeterminate margin.
    J Thorac Cardiovasc Surg. 2020;159:2042.
    PubMed    


  16. CHEN-YOSHIKAWA TF
    Commentary: A journey of a thousand miles begins with a single step.
    J Thorac Cardiovasc Surg. 2020;159:2092-2093.
    PubMed    


  17. SRINATHAN S
    Is ventilatory efficiency the next new thing in prehabilitation?
    J Thorac Cardiovasc Surg. 2020;159:e323-e324.
    PubMed    


  18. WAKEAM E, Adibfar A, Stokes S, Leighl NB, et al
    Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    J Thorac Cardiovasc Surg. 2020;159:2043-2054.
    PubMed     Abstract available


  19. MOLINA JC, Chaudry F, Menezes V, Ferraro P, et al
    Transvascular endosonographic-guided needle biopsy of intrathoracic lesions.
    J Thorac Cardiovasc Surg. 2020;159:2057-2065.
    PubMed     Abstract available


    April 2020
  20. DENLINGER CE
    Commentary: Durable activity of a tyrosine kinase inhibitor in lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 23. pii: S0022-5223(20)30985.
    PubMed    


  21. AZZOLI CG, Ng T
    Commentary: Preoperative gefitinib for stage II-III non-small cell lung cancer with EGFR mutation: A stich in time, or delay from stiches?
    J Thorac Cardiovasc Surg. 2020 Apr 18. pii: S0022-5223(20)30967.
    PubMed    


  22. HOANG CD
    Commentary: Smoke or fire? Resected lung cancer in never-smokers.
    J Thorac Cardiovasc Surg. 2020 Apr 10. pii: S0022-5223(20)30795.
    PubMed    


  23. LIM K, Hsin MKY
    Commentary: Resection for small cell lung cancer should be offered more often, and preferably anatomical.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30780.
    PubMed    


  24. JEFFREY YANG CF
    Commentary: Is surgery better than chemoradiation for T3N1M0 non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30805.
    PubMed    


  25. HATTORI A, Suzuki K, Takamochi K, Wakabayashi M, et al
    Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30734.
    PubMed     Abstract available


  26. LANUTI M
    Commentary: Wedge resection for limited-stage small cell lung cancer: Not an acceptable modality for curative intent.
    J Thorac Cardiovasc Surg. 2020 Apr 5. pii: S0022-5223(20)30811.
    PubMed    


  27. PASS HI
    Commentary: "Hot" gene signatures for checkpoint response prediction: A very cool idea.
    J Thorac Cardiovasc Surg. 2020;159:1611-1612.
    PubMed    


  28. WAKEAM E, Kidane B
    Commentary: Picking the winners-Leaning into selection bias.
    J Thorac Cardiovasc Surg. 2020;159:1594-1595.
    PubMed    


  29. BLESSING WA, Colson YL
    Commentary: The checkpoint before checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2020;159:1614-1615.
    PubMed    


  30. PATEL S, Kim AW
    Commentary: TiME may actually tell good from bad.
    J Thorac Cardiovasc Surg. 2020;159:1613-1614.
    PubMed    


  31. PASS HI
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1609-1610.
    PubMed    


  32. WOLF AS
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1556.
    PubMed    


  33. SUBRAMANIAN MP
    Commentary: Much to do about nodules-Improving care with a multidisciplinary pulmonary nodule clinic.
    J Thorac Cardiovasc Surg. 2020;159:1569-1570.
    PubMed    


  34. PARK CH, Lee SM, Lee JW, Hwang SH, et al
    Hook-wire localization versus lipiodol localization for patients with pulmonary lesions having ground-glass opacity.
    J Thorac Cardiovasc Surg. 2020;159:1571-1579.
    PubMed     Abstract available


  35. NGUYEN DM, Villamizar N
    Commentary: Preoperative localization of "hard-to-find" pulmonary ground-glass opacity: There are more than one way to find the target.
    J Thorac Cardiovasc Surg. 2020;159:1581-1583.
    PubMed    


  36. MADARIAGA ML, Lennes IT, Best T, Shepard JO, et al
    Multidisciplinary selection of pulmonary nodules for surgical resection: Diagnostic results and long-term outcomes.
    J Thorac Cardiovasc Surg. 2020;159:1558-1566.
    PubMed     Abstract available


  37. FELMLY LM, Gibney BC
    Commentary: Biphasic malignant mesothelioma-Survival of the fittest.
    J Thorac Cardiovasc Surg. 2020;159:1596-1597.
    PubMed    


  38. SESTI J, Paul S
    Commentary: GGOogle maps for the adult lung.
    J Thorac Cardiovasc Surg. 2020;159:1580.
    PubMed    


  39. LOCOCO F, Torricelli F, Lang-Lazdunski L, Veronesi G, et al
    Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    J Thorac Cardiovasc Surg. 2020;159:1584-1593.
    PubMed     Abstract available


    March 2020
  40. OPITZ I
    Commentary: Surgery expanding to stage IV non-small cell lung cancer treatment?!
    J Thorac Cardiovasc Surg. 2020 Mar 31. pii: S0022-5223(20)30731.
    PubMed    


  41. MITCHELL KG, Farooqi A, Ludmir EB, Corsini EM, et al
    Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30633.
    PubMed     Abstract available


  42. XIE D, Deng J, Gonzalez-Rivas D, Zhu Y, et al
    Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30719.
    PubMed     Abstract available


  43. CHAN EG, Chan PG, Mazur SN, Normolle DP, et al
    Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30706.
    PubMed     Abstract available


  44. PATNAIK SK, Cortes EG, Kannisto ED, Punnanitinont A, et al
    Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30631.
    PubMed     Abstract available


  45. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 22. pii: S0022-5223(20)30634.
    PubMed     Abstract available


  46. CHOI JJ, Huang J
    Commentary: How much is enough? The extent of resection in small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30588.
    PubMed    


  47. PASS HI
    Commentary: Lung cancer and dysbiosis: Debugging the studies for the future.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30619.
    PubMed    


  48. ZHANG Y, Fu F, Hu H, Wang S, et al
    Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30625.
    PubMed     Abstract available


    February 2020
  49. HONG TH, Kim J, Shin S, Kim HK, et al
    Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Feb 29. pii: S0022-5223(20)30518.
    PubMed     Abstract available


  50. RAHOUMA M, Kamel M, Nasar A, Harrison S, et al
    Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underuse of surgery.
    J Thorac Cardiovasc Surg. 2020 Feb 24. pii: S0022-5223(20)30503.
    PubMed     Abstract available


  51. JAKLITSCH MT, Jacobson FL
    The future of lung cancer screening with low-dose computed tomography.
    J Thorac Cardiovasc Surg. 2020 Feb 19. pii: S0022-5223(20)30199.
    PubMed    


  52. NGUYEN DM, Villamizar N
    Commentary: Lower airway microbiome and non-small cell lung cancer: The beginning of a bug story.
    J Thorac Cardiovasc Surg. 2020 Feb 14. pii: S0022-5223(20)30382.
    PubMed    


    January 2020
  53. ZHANG Y, Chen C, Hu J, Han Y, et al
    Early outcomes of robotic versus thoracoscopic segmentectomy for early-stage lung cancer: A multi-institutional propensity score-matched analysis.
    J Thorac Cardiovasc Surg. 2020 Jan 25. pii: S0022-5223(20)30226.
    PubMed     Abstract available


  54. WIESEL O, Burt BM
    Commentary: The A, C, G, and Ts of differentiating stage I and stage IV lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 17. pii: S0022-5223(19)37103.
    PubMed    


  55. LIN J
    Commentary: Through the looking glass: Is the consolidation/tumor ratio more important than size for clinical T1N0 lung cancer with a dominant ground-glass opacity?
    J Thorac Cardiovasc Surg. 2020 Jan 11. pii: S0022-5223(20)30071.
    PubMed    


  56. ITO H, Suzuki K, Mizutani T, Aokage K, et al
    Long-term survival outcome after lobectomy in patients with clinical T1 N0 lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 11. pii: S0022-5223(20)30054.
    PubMed     Abstract available


  57. RANDHAWA SK, Puri V
    Commentary: The changing risk paradigm in lung cancer: Are we opening Pandora's box?
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43494.
    PubMed    


  58. CHIDI A, Broderick SR
    Commentary: Chemo if you can-disparities in receipt of guideline-concordant adjuvant therapy in patients with locoregional non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43489.
    PubMed    


    December 2019
  59. WU J, Bai HX, Chan L, Su C, et al
    Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
    J Thorac Cardiovasc Surg. 2019 Dec 26. pii: S0022-5223(19)41497.
    PubMed     Abstract available


  60. YANG CJ, Berry MF
    Commentary: Resection of clinical early-stage lung cancer with unexpected nodal disease-can less really be the same?
    J Thorac Cardiovasc Surg. 2019 Dec 26. pii: S0022-5223(19)41495.
    PubMed    


  61. WHYTE RI
    Commentary: On-demand computed tomography screening for lung cancer-some surprising results.
    J Thorac Cardiovasc Surg. 2019 Dec 24. pii: S0022-5223(19)40870.
    PubMed    


  62. ZHENG R, Shen Q, Mardekian S, Solomides C, et al
    Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Dec 20. pii: S0022-5223(19)39883.
    PubMed     Abstract available


  63. BOYS J, Onaitis M
    Commentary: Breaking down non-small cell lung cancer tumor microenvironment heterogeneity and predicting response to immune checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2019 Dec 16. pii: S0022-5223(19)36852.
    PubMed    


  64. BRUNELLI A
    Commentary: Soft prognosticators following radical treatment of lung cancer: The time has come for a more integrated approach.
    J Thorac Cardiovasc Surg. 2019 Dec 14. pii: S0022-5223(19)37105.
    PubMed    


  65. LEE IH, Chen CY
    Commentary: The role of low-dose computed tomography for lung cancer screening among the nonsmoking Asian population.
    J Thorac Cardiovasc Surg. 2019 Dec 12. pii: S0022-5223(19)37081.
    PubMed    


  66. RHODIN KE, Rucker AJ, Ready NE, D'Amico TA, et al
    The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons.
    J Thorac Cardiovasc Surg. 2019 Dec 10. pii: S0022-5223(19)32182.
    PubMed     Abstract available


  67. NWOGU CE
    Commentary: Are two local therapies better than one for early-stage small cell lung cancer?
    J Thorac Cardiovasc Surg. 2019;158:1679.
    PubMed    


  68. SIHAG S
    Commentary: Surgery for N3 disease: Next frontier or has this ship already sailed?
    J Thorac Cardiovasc Surg. 2019;158:1695-1697.
    PubMed    


  69. YANG SC
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1675-1677.
    PubMed    


  70. HUANG J
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1691-1692.
    PubMed    


    November 2019
  71. VIEIRA A, Ugalde PA
    Commentary: Sleeve lobectomy for centrally located non-small cell lung cancer: Should the approach be a matter of debate?
    J Thorac Cardiovasc Surg. 2019 Nov 30. pii: S0022-5223(19)34024.
    PubMed    


  72. CHEN KN
    Commentary: Pay attention to low-risk populations for lung cancer, but cautiously interpret ground-glass nodules screened by low-dose computed tomography scan.
    J Thorac Cardiovasc Surg. 2019 Nov 27. pii: S0022-5223(19)33476.
    PubMed    


  73. PALEIRON N, Grassin F, Lancelin C, Tromeur C, et al
    Assessment of preoperative noninvasive ventilation before lung cancer surgery: The preOVNI randomized controlled study.
    J Thorac Cardiovasc Surg. 2019 Nov 23. pii: S0022-5223(19)33106.
    PubMed     Abstract available


  74. QIU T, Zhao Y, Xuan Y, Qin Y, et al
    Robotic sleeve lobectomy for centrally located non-small cell lung cancer: A propensity score-weighted comparison with thoracoscopic and open surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 22. pii: S0022-5223(19)33072.
    PubMed     Abstract available


  75. RAZI SS, Nguyen D, Villamizar N
    Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
    J Thorac Cardiovasc Surg. 2019 Nov 21. pii: S0022-5223(19)33080.
    PubMed     Abstract available


  76. FARROW NE, An SJ, Speicher PJ, Harpole DH Jr, et al
    Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 13. pii: S0022-5223(19)32486.
    PubMed     Abstract available


  77. JANG HJ, Lee HS, Ramos D, Park IK, et al
    Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2019 Nov 11. pii: S0022-5223(19)32515.
    PubMed     Abstract available


  78. PARK S, Ahn HJ, Yang M, Kim JA, et al
    The prognostic nutritional index and postoperative complications after curative lung cancer resection: A retrospective cohort study.
    J Thorac Cardiovasc Surg. 2019 Nov 6. pii: S0022-5223(19)32490.
    PubMed     Abstract available


  79. TITAN AL, He H, Lui N, Liou D, et al
    The influence of hormone replacement therapy on lung cancer incidence and mortality.
    J Thorac Cardiovasc Surg. 2019 Nov 5. pii: S0022-5223(19)32348.
    PubMed     Abstract available


  80. BRODERICK SR, Bott MJ
    Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019;158:1471-1474.
    PubMed    


  81. KNEUERTZ PJ, Cheufou DH, D'Souza DM, Mardanzai K, et al
    Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019;158:1457-1466.
    PubMed     Abstract available


  82. BERRY MF
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1465-1466.
    PubMed    


  83. CERFOLIO RJ
    Commentary: Do we have the right combatants? Should it be minimally invasive surgery versus therapy that removes no lymph nodes?
    J Thorac Cardiovasc Surg. 2019;158:1467-1468.
    PubMed    


  84. GONZALEZ-RIVAS D, Rami-Porta R
    Commentary: Intraoperative lymph node assessment by robotic, video-assisted thoracoscopic surgery, and thoracotomy: None meet the international recommendations.
    J Thorac Cardiovasc Surg. 2019;158:1469-1470.
    PubMed    


    October 2019
  85. KOZOWER BD
    Commentary: The association between hormone-replacement therapy and non-small cell lung cancer in women.
    J Thorac Cardiovasc Surg. 2019 Oct 15. pii: S0022-5223(19)32198.
    PubMed    


  86. KOZOWER BD
    Commentary: Lung cancer resection in the United States: Is regionalization the answer?
    J Thorac Cardiovasc Surg. 2019 Oct 15. pii: S0022-5223(19)32200.
    PubMed    


  87. LIU R, Kidane B
    Commentary: Detection is only part of the equation-Does elevated risk alone warrant screening?
    J Thorac Cardiovasc Surg. 2019;158:1255-1256.
    PubMed    



  88. Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1240-1241.
    PubMed    


    September 2019
  89. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 30. pii: S0022-5223(19)32082.
    PubMed     Abstract available


  90. SEPESI B, Cascone T
    Commentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time?
    J Thorac Cardiovasc Surg. 2019 Sep 24. pii: S0022-5223(19)32035.
    PubMed    


  91. ABBAS AE
    Commentary: Robotic anatomic lung resection: Raising the bar of our expectations in treating lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 24. pii: S0022-5223(19)32045.
    PubMed    


  92. SEPESI B
    Commentary: Surgery for N3 non-small cell lung cancer-utopia or future reality?
    J Thorac Cardiovasc Surg. 2019 Sep 23. pii: S0022-5223(19)31929.
    PubMed    


  93. TAYLOR M, Okereke I
    Commentary: Is radiation needed after resecting an early-stage small cell lung cancer?
    J Thorac Cardiovasc Surg. 2019 Sep 20. pii: S0022-5223(19)31888.
    PubMed    


  94. ALTORKI N, Stiles B
    Commentary: High-dose induction chemoradiation for lung cancer: The past is prologue.
    J Thorac Cardiovasc Surg. 2019 Sep 20. pii: S0022-5223(19)31873.
    PubMed    


  95. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31760.
    PubMed     Abstract available


  96. ENGELHARDT KE, Coughlin JM, DeCamp MM, Denlinger CE, et al
    Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection.
    J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31758.
    PubMed     Abstract available


  97. BOTT MJ
    Commentary: Cell proliferation and immune evasion: A dangerous combination.
    J Thorac Cardiovasc Surg. 2019;158:920-921.
    PubMed    


  98. DUX J, Grosser R, Adusumilli PS
    Commentary: Return to intended radiation therapy-Criteria for resection?
    J Thorac Cardiovasc Surg. 2019;158:930-931.
    PubMed    


    August 2019
  99. JIANG L, Huang W, Liu J, Harris K, et al
    Endosonography with lymph node sampling for restaging the mediastinum in lung cancer: A systematic review and pooled data analysis.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31649.
    PubMed     Abstract available


  100. YAMAMICHI T, Shimada Y, Masuno R, Ohira T, et al
    Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31659.
    PubMed     Abstract available


  101. PANI E, Kennedy G, Zheng X, Ukert B, et al
    Factors associated with nodal metastasis in 2-centimeter or less non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Aug 25. pii: S0022-5223(19)31643.
    PubMed     Abstract available


    July 2019
  102. DONINGTON JS, Martin LW
    Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2019;158:287-288.
    PubMed    


  103. MOLINA JC, Liberman M
    Commentary: Pulling an entire lung out of a small incision-Video-assisted thoracoscopic surgical pneumonectomy, the final frontier in minimally invasive thoracic surgery.
    J Thorac Cardiovasc Surg. 2019;158:267-268.
    PubMed    


    May 2019
  104. LUI NS
    Commentary: Should lung cancer screening guidelines go up in smoke?
    J Thorac Cardiovasc Surg. 2019 May 31. pii: S0022-5223(19)31140.
    PubMed    


  105. GROTH SS, Ripley RT, Carrott P, Burt BM, et al
    Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma.
    J Thorac Cardiovasc Surg. 2019 May 30. pii: S0022-5223(19)31150.
    PubMed    


  106. KOZOWER BD
    Commentary: Invasive mediastinal staging for patients with lung cancer-We need to do better!
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31112.
    PubMed    


  107. FARJAH F, Silvestri GA, Wood DE
    Commentary: Invasive mediastinal staging for lung cancer-Quality gap, evidence gap, both?
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31113.
    PubMed    


  108. BRAVO-INIGUEZ CE, Fox SW, De Leon LE, Tarascio JN, et al
    Cumulative nonsmoking risk factors increase the probability of developing lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 18. pii: S0022-5223(19)31038.
    PubMed     Abstract available


  109. MITCHELL KG, Parra ER, Nelson DB, Zhang J, et al
    Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 17. pii: S0022-5223(19)31015.
    PubMed     Abstract available


  110. LUI NS
    Commentary: Pleomorphic carcinoma: An aggressive type of non-small cell lung cancer that should be treated like the others.
    J Thorac Cardiovasc Surg. 2019 May 16. pii: S0022-5223(19)31004.
    PubMed    


  111. NELSON DB, Tayob N, Nguyen QN, Erasmus J, et al
    Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2019 May 11. pii: S0022-5223(19)30972.
    PubMed     Abstract available


  112. OSAROGIAGBON RU, Lee YS, Faris NR, Ray MA, et al
    Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    J Thorac Cardiovasc Surg. 2019 May 2. pii: S0022-5223(19)30968.
    PubMed     Abstract available


  113. PREDINA JD, Newton AD, Corbett C, Shin M, et al
    Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas.
    J Thorac Cardiovasc Surg. 2019;157:2061-2069.
    PubMed     Abstract available


  114. KAMEL MK, Lee B, Harrison S, Port JL, et al
    Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?
    J Thorac Cardiovasc Surg. 2019;157:2038-2046.
    PubMed     Abstract available


    April 2019
  115. LANUTI M
    Commentary: Cautious optimism for induction immunotherapy in resectable lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30926.
    PubMed    


  116. ALTORKI N, Lee B
    Commentary: Lobectomy or sublobar resection for early lung cancer: One small step for surgeons, one giant step for patients.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30903.
    PubMed    


  117. HENDRIKSEN BS, Hollenbeak CS, Reed MF, Taylor MD, et al
    Perioperative chemotherapy is not associated with improved survival in stage I pleomorphic lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 17. pii: S0022-5223(19)30824.
    PubMed     Abstract available


    March 2019
  118. MOORE CB, Cox ML, Mulvihill MS, Klapper J, et al
    Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 28. pii: S0022-5223(19)30702.
    PubMed     Abstract available


  119. NELSON DB, Mehran RJ, Mitchell KG, Correa AM, et al
    Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 21. pii: S0022-5223(19)30677.
    PubMed     Abstract available


  120. SUBRAMANIAN M, Liu J, Greenberg C, Schumacher J, et al
    Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?
    J Thorac Cardiovasc Surg. 2019;157:1205-1217.
    PubMed     Abstract available


  121. ODELL DD, Feinglass J, Engelhardt K, Papastefan S, et al
    Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
    J Thorac Cardiovasc Surg. 2019;157:1219-1235.
    PubMed     Abstract available



  122. Discussion.
    J Thorac Cardiovasc Surg. 2019;157:1231-1235.
    PubMed    


    February 2019
  123. STILES BM, Mao J, Harrison S, Lee B, et al
    Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2019 Feb 28. pii: S0022-5223(19)30533.
    PubMed     Abstract available


  124. VAN BERKEL V
    Commentary: Still not enough data yet-Sublobar resection versus lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30461.
    PubMed    


  125. GRAVIER FE, Bonnevie T, Boujibar F, Medrinal C, et al
    Effect of prehabilitation on ventilatory efficiency in non-small cell lung cancer patients: A cohort study.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30448.
    PubMed     Abstract available


  126. LATIF MJ, Tan KS, Molena D, Huang J, et al
    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 12. pii: S0022-5223(19)30351.
    PubMed     Abstract available


    January 2019
  127. SALTER KD, Burt BM
    Commentary: Postoperative blood transplantation for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Jan 25. pii: S0022-5223(19)30259.
    PubMed    


  128. GUCKENBERGER M, Aerts JG, Van Schil P, Weder W, et al
    The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.
    J Thorac Cardiovasc Surg. 2019;157:358-361.
    PubMed    


  129. GROTH SS, Ripley RT, Burt BM
    A thinner peel to peel: Pleural thickness is prognostic in mesothelioma.
    J Thorac Cardiovasc Surg. 2019;157:414-415.
    PubMed    


  130. SEMENKOVICH TR, Puri V
    Surgery versus stereotactic body radiation therapy: Definitive evidence is still elusive.
    J Thorac Cardiovasc Surg. 2019;157:374-375.
    PubMed    


  131. OKADA M, Miyata Y, Takamochi K, Tsutani Y, et al
    Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery.
    J Thorac Cardiovasc Surg. 2019;157:388-395.
    PubMed     Abstract available


    December 2018
  132. SAMSON P
    It's time to check our bias: Ensuring health equity for patients with lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 27. pii: S0022-5223(18)33499.
    PubMed    


  133. HSIN MK, Ho JC
    It is not as bad as they say: The risks of surgery in screening-detected lung cancer are overstated.
    J Thorac Cardiovasc Surg. 2018 Dec 25. pii: S0022-5223(18)33482.
    PubMed    


  134. YANG CJ, Yendamuri S, Mayne NR, Battoo A, et al
    The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.
    J Thorac Cardiovasc Surg. 2018 Dec 18. pii: S0022-5223(18)33419.
    PubMed     Abstract available


  135. BOTT MJ, Yang SC, Park BJ, Adusumilli PS, et al
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 13. pii: S0022-5223(18)33277.
    PubMed     Abstract available


  136. WOLF A, Alpert N, Tran BV, Liu B, et al
    Persistence of racial disparities in early-stage lung cancer treatment.
    J Thorac Cardiovasc Surg. 2018 Dec 11. pii: S0022-5223(18)33258.
    PubMed     Abstract available


  137. FERRARI-LIGHT D, Cerfolio RJ
    Are we really operating on advanced stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2018 Dec 4. pii: S0022-5223(18)33219.
    PubMed    


  138. OKAMURA A, Watanabe M, Hayami M, Mine S, et al
    Esophagectomy via upper partial sternotomy for esophageal cancer after previous right pneumonectomy: A case report.
    J Thorac Cardiovasc Surg. 2018;156:e217-e220.
    PubMed    


    November 2018
  139. FERNANDEZ FG, Kosinski AS, Tong BC, Furnary AP, et al
    Lack of correlation between short- and long-term performance after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018 Nov 27. pii: S0022-5223(18)33141.
    PubMed     Abstract available


  140. NELSON DB, Tayob N, Mitchell KG, Correa AM, et al
    Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2018 Nov 26. pii: S0022-5223(18)33149.
    PubMed     Abstract available


  141. DAVID EA, Andersen SW, Beckett LA, Melnikow J, et al
    Survival benefits associated with surgery for advanced non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 14. pii: S0022-5223(18)32941.
    PubMed     Abstract available


  142. DONINGTON JS
    Keeping surgery relevant in oligometastatic non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 8. pii: S0022-5223(18)32903.
    PubMed    


  143. HARRISON MS, Frye CC, Puri V
    Health metrics in lung cancer care: Measure, improve, repeat.
    J Thorac Cardiovasc Surg. 2018 Nov 2. pii: S0022-5223(18)32879.
    PubMed    


    October 2018
  144. KORST RJ, Santana-Joseph S
    Quality metrics for lung cancer care: Far from perfect, but close to reality.
    J Thorac Cardiovasc Surg. 2018 Oct 28. pii: S0022-5223(18)32858.
    PubMed    


  145. SUBRAMANIAN MP, Puri V
    Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.
    J Thorac Cardiovasc Surg. 2018 Oct 26. pii: S0022-5223(18)32833.
    PubMed    


  146. FARJAH F, Kessler L
    Rightsizing lung cancer surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 22. pii: S0022-5223(18)32803.
    PubMed    


  147. ZHANG Y, Chen H
    Neoadjuvant or adjuvant chemotherapy for non-small-cell lung cancer: Does the timing matter?
    J Thorac Cardiovasc Surg. 2018 Oct 12. pii: S0022-5223(18)32632.
    PubMed    


  148. BRUNELLI A
    The timing of chemotherapy in multimodality treatment of locally advanced lung cancer: One size does not fit all.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32609.
    PubMed    


  149. BRANDT WS, Yan W, Zhou J, Tan KS, et al
    Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32606.
    PubMed     Abstract available


  150. WANG Y, Yeung JC, Hanna WC, Allison F, et al
    Metachronous or synchronous primary lung cancer in the era of computed tomography surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 6. pii: S0022-5223(18)32556.
    PubMed     Abstract available


    September 2018
  151. CAO C, Wang D, Chung C, Tian D, et al
    A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Sep 15. pii: S0022-5223(18)32347.
    PubMed     Abstract available


  152. ENGELHARDT KE, Feinglass JM, DeCamp MM, Bilimoria KY, et al
    Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time-trend analysis of the National Cancer Data Base.
    J Thorac Cardiovasc Surg. 2018;156:1233-1246.
    PubMed     Abstract available


    August 2018
  153. FERNANDEZ-RODRIGUEZ L, Torres I, Romera D, Galera R, et al
    Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography.
    J Thorac Cardiovasc Surg. 2018 Aug 2. pii: S0022-5223(18)32018.
    PubMed     Abstract available


    July 2018
  154. LIN J, Fernandez F
    Indications for invasive mediastinal staging for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Jul 21. pii: S0022-5223(18)31872.
    PubMed    


  155. HOANG CD
    Adjuvant chemotherapy in stage I lung cancer: Is more better?
    J Thorac Cardiovasc Surg. 2018 Jul 19. pii: S0022-5223(18)31821.
    PubMed    


  156. WANG S, Xu J, Wang R, Qian F, et al
    Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    J Thorac Cardiovasc Surg. 2018 Jul 18. pii: S0022-5223(18)31779.
    PubMed     Abstract available


  157. UPHAM TC, Onaitis MW
    Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;156:365-368.
    PubMed    


    June 2018
  158. SCHRUMP DS, Hong JA
    Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2632-2633.
    PubMed    


    May 2018
  159. HATTORI A, Suzuki K
    New era defining a novel clinical T staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2179-2180.
    PubMed    


    April 2018
  160. SWANSON SJ
    Good vibrations-better care for lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Apr 13. pii: S0022-5223(18)30994.
    PubMed    


  161. BRUNELLI A
    It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30962.
    PubMed    


  162. OKIROR L, Harling L, Toufektzian L, King J, et al
    Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30935.
    PubMed     Abstract available


  163. CAO J, Xu J, He Z, Yuan P, et al
    Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2018 Apr 6. pii: S0022-5223(18)30905.
    PubMed     Abstract available


  164. YENDAMURI S, Dhillon SS, Groman A, Dy G, et al
    Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    J Thorac Cardiovasc Surg. 2018 Apr 4. pii: S0022-5223(18)30895.
    PubMed     Abstract available


  165. MAO Q, Xia W, Dong G, Chen S, et al
    A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    J Thorac Cardiovasc Surg. 2018;155:1784-1792.
    PubMed     Abstract available


    March 2018
  166. KRUSER TJ, Mohindra N, DeCamp MM
    One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer management.
    J Thorac Cardiovasc Surg. 2018 Mar 29. pii: S0022-5223(18)30865.
    PubMed    


  167. ISBELL JM, Jones DR, Li BT
    Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30707.
    PubMed    


  168. AJMANI GS, Wang CH, Kim KW, Howington JA, et al
    Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30776.
    PubMed     Abstract available


  169. CAMERON RB
    Adherence to lung cancer surgical quality standards is critical for the survival of both our patients and our specialty.
    J Thorac Cardiovasc Surg. 2018 Mar 7. pii: S0022-5223(18)30612.
    PubMed    


  170. SU K, Gao S, Ying J, Zou S, et al
    Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B.
    J Thorac Cardiovasc Surg. 2018 Mar 6. pii: S0022-5223(18)30059.
    PubMed    


  171. ROCCO G
    Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 2. pii: S0022-5223(18)30604.
    PubMed    


  172. BRUNELLI A
    Short-term outcomes do not capture the real value of lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018;155:1311-1312.
    PubMed    


  173. MEHRAN RJ, Martin LW, Roth JA
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:1307.
    PubMed    


    February 2018
  174. SEPESI B, Ye Y, Mitchell KG, Zhang L, et al
    Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Feb 15. pii: S0022-5223(18)30372.
    PubMed     Abstract available


  175. CHENG X, Zheng D, Li Y, Li H, et al
    Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30362.
    PubMed     Abstract available


  176. MUNOZ-LARGACHA JA, Steiling KA, Kathuria H, Charlot M, et al
    Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30308.
    PubMed     Abstract available


  177. THORNBLADE LW, Wood DE, Mulligan MS, Farivar AS, et al
    Variability in invasive mediastinal staging for lung cancer: A multicenter regional study.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30311.
    PubMed     Abstract available


  178. RUSTHOVEN CG, Jones BL, Kavanagh BD
    Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:810-811.
    PubMed    


    January 2018
  179. AHMAD U, Machuzak M
    Electric shock therapy for lung cancer: Taking palliation to the next level.
    J Thorac Cardiovasc Surg. 2018 Jan 31. pii: S0022-5223(18)30245.
    PubMed    


  180. MOGHANAKI D, Simone CB 2nd, Rimner A, Karas TZ, et al
    The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:429-431.
    PubMed    


    December 2017
  181. NOMORI H, Shiraishi A, Cong Y, Shoji K, et al
    Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 26. pii: S0022-5223(17)33059.
    PubMed     Abstract available


  182. RUSCH VW, Chaft J, Hellmann M
    KEYNOTE-024: Unlocking a pathway to lung cancer cure?
    J Thorac Cardiovasc Surg. 2017 Dec 23. pii: S0022-5223(17)33029.
    PubMed    


  183. ROGERS LJ, Bleetman D, Messenger DE, Joshi NA, et al
    The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32855.
    PubMed     Abstract available


  184. DRAKE JA, Sullivan JL, Weksler B
    Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32857.
    PubMed     Abstract available


  185. DIGESU CS, Hachey KJ, Gilmore DM, Khullar OV, et al
    Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32505.
    PubMed     Abstract available


  186. BRUNELLI A
    Time of modeling survival of patients with stage III-N2 non-small cell lung cancer: Before or after surgery makes a difference.
    J Thorac Cardiovasc Surg. 2017 Dec 12. pii: S0022-5223(17)32837.
    PubMed    


    November 2017
  187. GELLER AD, Zheng H, Mathisen DJ, Wright CD, et al
    Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 20. pii: S0022-5223(17)32702.
    PubMed     Abstract available


  188. NEGRAO MV, Quek K, Zhang J, Sepesi B, et al
    TRACERx: Tracking tumor evolution to impact the course of lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 16. pii: S0022-5223(17)32689.
    PubMed    


  189. FERNANDEZ FG, Kosinski AS, Furnary AP, Onaitis M, et al
    Differential effects of operative complications on survival after surgery for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 13. pii: S0022-5223(17)32503.
    PubMed     Abstract available


  190. WEKSLER B
    Resection of pleural implants in patients with lung cancer should remain the exception rather than the rule.
    J Thorac Cardiovasc Surg. 2017 Nov 8. pii: S0022-5223(17)32459.
    PubMed    


  191. LIN J
    Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32471.
    PubMed    


  192. CHENG X, Chen H
    Commentary on the impacts of postoperative complications on survival after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32470.
    PubMed    


  193. ZHENG D, Ye T, Hu H, Zhang Y, et al
    Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 3. pii: S0022-5223(17)32409.
    PubMed     Abstract available


  194. LIU M, Wigle D, Wampfler JA, Dai J, et al
    T category of non-small cell lung cancer invading the fissure to the adjacent lobe.
    J Thorac Cardiovasc Surg. 2017;154:1777-1783.
    PubMed     Abstract available


  195. LANUTI M
    Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.
    J Thorac Cardiovasc Surg. 2017 Nov 1. pii: S0022-5223(17)32392.
    PubMed    


    October 2017
  196. MOLENA D
    Shining light on sentinel node assessment for lung cancer: Quality is superior to quantity.
    J Thorac Cardiovasc Surg. 2017 Oct 20. pii: S0022-5223(17)32331.
    PubMed    


    September 2017
  197. DETTERBECK FC
    The eighth edition TNM stage classification for lung cancer: What does it mean on main street?
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32136.
    PubMed    


  198. ZHANG Z, Mostofian F, Ivanovic J, Gilbert S, et al
    All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32135.
    PubMed     Abstract available


  199. TURNA A, Melek H, Kara HV, Kilic B, et al
    Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Sep 27. pii: S0022-5223(17)32131.
    PubMed     Abstract available


  200. CERFOLIO RJ, Ghanim AF, Dylewski M, Veronesi G, et al
    The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.
    J Thorac Cardiovasc Surg. 2017 Sep 18. pii: S0022-5223(17)31919.
    PubMed     Abstract available


  201. GILBERT CR, Ely R, Fathi JT, Louie BE, et al
    The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
    J Thorac Cardiovasc Surg. 2017 Sep 13. pii: S0022-5223(17)31890.
    PubMed     Abstract available


  202. SEDER CW
    Lung cancer screening is here to stay, but does it pay?
    J Thorac Cardiovasc Surg. 2017 Sep 12. pii: S0022-5223(17)31887.
    PubMed    


  203. ANTONOFF MB
    Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?
    J Thorac Cardiovasc Surg. 2017 Sep 8. pii: S0022-5223(17)31866.
    PubMed    


  204. TONG BC
    Lung cancer screening: No more excuses.
    J Thorac Cardiovasc Surg. 2017 Sep 5. pii: S0022-5223(17)31853.
    PubMed    


  205. LIU C, Liu L
    Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134.
    PubMed    


  206. DIGESU CS, Colson YL
    A "green" light for staging in early lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134-1136.
    PubMed    


  207. FLORES RM
    Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31820.
    PubMed    


  208. KIDANE B
    Stereotactic body radiation therapy versus video-assisted thoracoscopic surgery in stage I lung cancer: Honesty in the face of uncertainty.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31821.
    PubMed    


  209. HATTORI A, Matsunaga T, Takamochi K, Oh S, et al
    Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31798.
    PubMed     Abstract available


  210. BURT BM
    Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31823.
    PubMed    


    August 2017
  211. CORNWELL LD, Echeverria AE, Samuelian J, Mayor J, et al
    Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    J Thorac Cardiovasc Surg. 2017 Aug 16. pii: S0022-5223(17)31718.
    PubMed     Abstract available


    July 2017
  212. FERNANDEZ FG
    What are the gaps in quality measurement for lung cancer surgery?
    J Thorac Cardiovasc Surg. 2017 Jul 1. pii: S0022-5223(17)31367.
    PubMed    


    June 2017
  213. SCHAHEEN LW, D'Cunha J
    The slippery slope of nonoperative therapy in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Jun 10. pii: S0022-5223(17)31178.
    PubMed    


  214. BRANDT WS, Isbell JM, Jones DR
    Defining quality in the surgical care of lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31171.
    PubMed    


    May 2017
  215. CHEN K, Zhang J, Guan T, Yang F, et al
    Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 24. pii: S0022-5223(17)31084.
    PubMed     Abstract available


  216. ZHAO Y, Li G, Zhang Y, Hu H, et al
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 20. pii: S0022-5223(17)31049.
    PubMed     Abstract available


  217. NGUYEN DM, Villamizar N
    "One-stop shop" tumor tattooing and sentinel lymph node mapping: A new paradigm for lung cancer therapy.
    J Thorac Cardiovasc Surg. 2017 May 17. pii: S0022-5223(17)30908.
    PubMed    


    April 2017
  218. WEKSLER B
    One in every 14 patients with early-stage lung cancer is not being treated!
    J Thorac Cardiovasc Surg. 2017 Apr 24. pii: S0022-5223(17)30850.
    PubMed    


  219. HOANG CD
    Protein-based prognostic biomarkers in lung cancer: Promise or pitfall?
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30851.
    PubMed    


  220. FERRARIS VA
    Interstitial lung disease and lung cancer: Decisions, precision, and tuna fish sandwiches.
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30848.
    PubMed    


  221. BURT BM
    Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?
    J Thorac Cardiovasc Surg. 2017 Apr 12. pii: S0022-5223(17)30689.
    PubMed    


  222. BERRY MF
    Evidence for resection of sarcoma pulmonary metastases: More, but better?
    J Thorac Cardiovasc Surg. 2017 Apr 7. pii: S0022-5223(17)30658.
    PubMed    


  223. MCMURRY TL, Shah PM, Samson P, Robinson CG, et al
    Treatment of stage I non-small cell lung cancer: What's trending?
    J Thorac Cardiovasc Surg. 2017 Apr 5. pii: S0022-5223(17)30643.
    PubMed     Abstract available


  224. YEROKUN BA, Yang CJ, Gulack BC, Li X, et al
    A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30639.
    PubMed     Abstract available


  225. TSUTANI Y, Mimura T, Kai Y, Ito M, et al
    Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30635.
    PubMed     Abstract available


  226. SMELTZER MP, Lin CC, Kong FS, Jemal A, et al
    Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30604.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: